by MM360 Staff | May 30, 2025 | Uncategorized
Source: ASCO Daily News In the first episode of a special daily series during the 2025 ASCO Annual Meeting, Dr. John Sweetenham discusses the results of 2 studies on the treatment of advanced colorectal cancer plus an additional study exploring the association of...
by MM360 Staff | May 30, 2025 | Uncategorized
Source: CureToday articles New treatment combinations are transforming genitourinary cancer care, improving survival and quality of life while personalizing patient outcomes. Read More
by MM360 Staff | May 30, 2025 | Uncategorized
Source: CureToday articles Antihistamines may be associated with survival improvement in patients with metastatic urothelial carcinoma receiving Tecentriq. Read More
by MM360 Staff | May 30, 2025 | Uncategorized
Source: CureToday articles There are many instances where teddy bears can be the key to opening hearts and minds during cancer care. Read More
by MM360 Staff | May 30, 2025 | Uncategorized
Source: CureToday articles The phase 1/2 STARLIGHT-1 trial has dosed the first patient in the second cohort of the study evaluating EB103 in advanced B-cell non-Hodgkin’s lymphomas. Read More
by MM360 Staff | May 30, 2025 | Uncategorized
Source: CureToday articles Blocking serotonin transporters with antidepressants boosted CD8 T cell function and enhanced immunotherapy response in mouse and human tumor models. Read More
